Published in Radiology on April 01, 1999
Primary small intestinal lymphoma presenting as a groin abscess. Saudi J Gastroenterol (2009) 0.75
Intussusception of a small bowel large B-cell lymphoma. Indian J Surg Oncol (2014) 0.75
Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Colon: A Case Report and a Literature Review. Am J Case Rep (2017) 0.75
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys (1995) 15.12
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol (1998) 8.40
Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science (1987) 4.02
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med (2001) 3.51
Structure of the 3' terminus of the hepatitis C virus genome. J Virol (1996) 3.40
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol (1994) 3.22
Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer (2001) 2.59
A novel sequence found at the 3' terminus of hepatitis C virus genome. Biochem Biophys Res Commun (1995) 2.58
The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med (1998) 2.57
Molecular cloning of hepatitis C virus genome from a single Japanese carrier: sequence variation within the same individual and among infected individuals. Virus Res (1992) 2.56
Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma. J Clin Oncol (1990) 2.46
Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys (1999) 2.29
Primary hepatic lymphoma: favorable outcome after combination chemotherapy. Cancer (2001) 2.08
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation. Int J Radiat Oncol Biol Phys (1995) 2.05
Clinical course of solitary extramedullary plasmacytoma. Radiother Oncol (1999) 2.05
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood (1988) 1.95
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med (1980) 1.91
Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res (1996) 1.89
The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience. Int J Radiat Oncol Biol Phys (1991) 1.88
Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med (1994) 1.75
A novel cold-inducible zinc finger protein from soybean, SCOF-1, enhances cold tolerance in transgenic plants. Plant J (2001) 1.74
Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma. Ann Intern Med (1997) 1.71
High-resolution crystal structures of delta5-3-ketosteroid isomerase with and without a reaction intermediate analogue. Biochemistry (1997) 1.71
Mantle-cell lymphoma. Lancet Oncol (2001) 1.70
Catalysis by metal-activated hydroxide in zinc and manganese metalloenzymes. Annu Rev Biochem (1999) 1.67
Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development. Biochemistry (1998) 1.66
Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst (1995) 1.66
Analysis of the probability and risk of cause-specific failure. Int J Radiat Oncol Biol Phys (1994) 1.65
Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys (1997) 1.65
Standards for diagnosis and management of invasive breast carcinoma. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology. CA Cancer J Clin (1998) 1.65
Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood (2001) 1.64
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol (1998) 1.64
Involvement of specific calmodulin isoforms in salicylic acid-independent activation of plant disease resistance responses. Proc Natl Acad Sci U S A (1999) 1.61
Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys (1998) 1.56
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood (1998) 1.54
Monoclonal antibodies against Helicobacter pylori cross-react with human tissue. Helicobacter (1997) 1.54
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys (2000) 1.54
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis. Blood (1995) 1.52
Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys (1989) 1.52
Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum. Biochemistry (2001) 1.51
Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy. Ann Oncol (2012) 1.50
Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys (1991) 1.50
Plasma cell granuloma of the nasal cavity treated by radiation therapy. Cancer (1991) 1.45
Primary lymphoma of the prostate: good outcome with doxorubicin-based combination chemotherapy. J Urol (1995) 1.45
T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease. Am J Surg Pathol (1996) 1.42
Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group. Am Rev Respir Dis (1979) 1.41
Outcomes of high-dose unilateral kidney irradiation in patients with gastric lymphoma. Int J Radiat Oncol Biol Phys (1998) 1.41
Results of a changing treatment philosophy for children with stage I Hodgkin's disease: a 35-year experience. Med Pediatr Oncol (1991) 1.39
Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience. Int J Radiat Oncol Biol Phys (1999) 1.39
Is long-term survival possible with external beam irradiation for stage D1 adenocarcinoma of the prostate? Cancer (1992) 1.38
Prognostic factors with high-dose melphalan for refractory multiple myeloma. Blood (1988) 1.36
Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int J Radiat Oncol Biol Phys (2000) 1.34
Identification of rice blast fungal elicitor-responsive genes by differential display analysis. Mol Plant Microbe Interact (2000) 1.31
Clinical practice guidelines on the Internet. A structured, scalable approach. MD Comput (1999) 1.31
Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma. J Clin Oncol (1995) 1.30
A strategy for the identification of proteins targeted by thioredoxin. Proc Natl Acad Sci U S A (2001) 1.30
Novel 5' exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma. Am J Pathol (1998) 1.29
AtBAG6, a novel calmodulin-binding protein, induces programmed cell death in yeast and plants. Cell Death Differ (2006) 1.25
Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy. Gynecol Oncol (1997) 1.23
In response to Bentzen et al., IJROBP 32:1531-1534; 1995. Int J Radiat Oncol Biol Phys (1995) 1.21
Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage. Am J Pathol (2001) 1.21
Food group contributions to nutrient intake in whites, blacks, and Mexican Americans in Texas. J Am Diet Assoc (1989) 1.21
Cranial irradiation in cancer of the lung of all cell types. JAMA (1981) 1.21
Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants. J Clin Oncol (1997) 1.21
Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol (1999) 1.19
Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy. Cancer (1995) 1.19
Richter's syndrome: a report on 39 patients. J Clin Oncol (1993) 1.19
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. J Natl Cancer Inst (1997) 1.19
A structural protein of hepatitis C virus expressed in E. coli facilitates accurate detection of hepatitis C virus. Biochem Biophys Res Commun (1990) 1.19
Molecular analysis of rice plants harboring an Ac/Ds transposable element-mediated gene trapping system. Plant J (1999) 1.19
Localized primary non-Hodgkin lymphoma of the breast. Am J Clin Oncol (1998) 1.18
Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer (1997) 1.17
Chemical stability of prostacyclin (PGI2) in aqueous solutions. Prostaglandins (1978) 1.17
A dynamin-like protein in Arabidopsis thaliana is involved in biogenesis of thylakoid membranes. EMBO J (1998) 1.16
Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer Treat Rep (1981) 1.14
Localized primary malignant lymphoma of bone. Int J Radiat Oncol Biol Phys (1997) 1.14
A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels. J Clin Oncol (1989) 1.13
Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment. Radiother Oncol (2001) 1.13
Nephrotoxicity of combined cephalothin-gentamicin regimen. Arch Intern Med (1975) 1.12
Is chest radiotherapy necessary in any or all patients with small cell carcinoma of the lung? Yes. Cancer Treat Rep (1983) 1.11
Isolation of two soybean G-box binding factors which interact with a G-box sequence of an auxin-responsive gene. Plant J (1995) 1.11
A dynamin-like protein, ADL1, is present in membranes as a high-molecular-mass complex in Arabidopsis thaliana. Plant Physiol (1997) 1.10
Molecular cloning and targeting of a fibrillarin homolog from Arabidopsis. Plant Physiol (2000) 1.10
Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol (1995) 1.10
Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies. Br J Haematol (1997) 1.10
Long-term results with radiotherapy for Stage I-II follicular lymphomas. Int J Radiat Oncol Biol Phys (2001) 1.09
Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy. J Clin Oncol (1984) 1.09
Two hevein homologs isolated from the seed of Pharbitis nil L. exhibit potent antifungal activity. Biochim Biophys Acta (1998) 1.09
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma. J Clin Oncol (1996) 1.08